0000914475-13-000049.txt : 20130701
0000914475-13-000049.hdr.sgml : 20130701
20130701173434
ACCESSION NUMBER: 0000914475-13-000049
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20130627
FILED AS OF DATE: 20130701
DATE AS OF CHANGE: 20130701
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: NEUROCRINE BIOSCIENCES INC
CENTRAL INDEX KEY: 0000914475
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 330525145
STATE OF INCORPORATION: CA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 12780 EL CAMINO REAL
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
BUSINESS PHONE: (858) 617-7600
MAIL ADDRESS:
STREET 1: 12780 EL CAMINO REAL
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Grigoriadis Dimitri E.
CENTRAL INDEX KEY: 0001423838
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-22705
FILM NUMBER: 13945761
MAIL ADDRESS:
STREET 1: 12790 EL CAMINO REAL
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
4
1
edgar.xml
PRIMARY DOCUMENT
X0306
4
2013-06-27
0000914475
NEUROCRINE BIOSCIENCES INC
NBIX
0001423838
Grigoriadis Dimitri E.
NEUROCRINE BIOSCIENCES, INC.
12780 EL CAMINO REAL
SAN DIEGO
CA
92130
0
1
0
0
Chief Research Officer
Common Stock
2013-06-27
4
S
0
3837
13.00
D
75433
D
Nonstatutory Stock Option
10.90
2013-06-27
4
X
0
3837
10.90
A
2007-09-26
2013-09-26
Comon Stock
3837
0
D
Exercise of in-the-money or at-the money derivative security
The disposition reported in this Form 4 was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person at least 90 days prior to the transaction date in Box 3 above. Additionally, Issuer policy restricts the Reporting Person from amending, canceling, suspending or otherwise modifying any 10b5-1 trading plan subsequent to adoption of the plan.
Represents a weighted average price. These shares were sold in mulitple transactions at prices ranging from $13.00-$13.01, inclusive. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
Margaret E. Valeur-Jensen, By Power of Attorney
2013-07-01